Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q321431> ?p ?o }
- Q321431 wikiPageWikiLink Q6581305.
- Q321431 wikiPageWikiLink Q692536.
- Q321431 wikiPageWikiLink Q7168709.
- Q321431 wikiPageWikiLink Q7180724.
- Q321431 wikiPageWikiLink Q7180990.
- Q321431 wikiPageWikiLink Q7335370.
- Q321431 wikiPageWikiLink Q794086.
- Q321431 wikiPageWikiLink Q797061.
- Q321431 wikiPageWikiLink Q815819.
- Q321431 wikiPageWikiLink Q824258.
- Q321431 wikiPageWikiLink Q8256003.
- Q321431 wikiPageWikiLink Q84.
- Q321431 wikiPageWikiLink Q8420198.
- Q321431 wikiPageWikiLink Q851162.
- Q321431 wikiPageWikiLink Q8522217.
- Q321431 wikiPageWikiLink Q917069.
- Q321431 wikiPageWikiLink Q918753.
- Q321431 wikiPageWikiLink Q929737.
- Q321431 wikiPageWikiLink Q9384.
- Q321431 wikiPageWikiLink Q9625.
- Q321431 atcPrefix "L02".
- Q321431 atcSuffix "BX03".
- Q321431 casNumber "154229".
- Q321431 iupacName "-17".
- Q321431 pubchem "132971".
- Q321431 unii "G819A456D0".
- Q321431 type ChemicalSubstance.
- Q321431 type Drug.
- Q321431 type ChemicalObject.
- Q321431 type Thing.
- Q321431 type Q8386.
- Q321431 comment "Abiraterone acetate (INN, USAN, BAN, JAN) (brand names Zytiga, Abiratas, Abretone, Abirapro) is a steroidal antiandrogen, specifically an androgen synthesis inhibitor, used in combination with prednisone in metastatic castration-resistant prostate cancer (previously called hormone-resistant or hormone-refractory prostate cancer) – i.e., prostate cancer not responding to androgen deprivation or treatment with androgen receptor antagonists.".
- Q321431 label "Abiraterone acetate".
- Q321431 depiction Abiraterone.svg.